Trial Profile
Peripheral Pharmacodynamics of Topiramate-Phentermine in Obese Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Phentermine/topiramate (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 10 Feb 2015 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov
- 25 Mar 2014 Planned End Date changed from 1 Apr 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov.
- 25 Mar 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.